Press Release
Category Added in a WPeMatico Campaign
-
AbbVie Presents New Data Across Its Blood Cancer Portfolio at EHA 2026
Data being presented, including six oral presentations, reinforce AbbVie’s leadership and commitment to ongoing research to improve outcomes for people…
Read More » -
Sapiens Strengthens Americas Push, Appointing EVP Sales to Lead Growth
Veteran insurtech sales leader joins to accelerate revenue growth and go-to-market execution across the Americas as Sapiens expands its AI strategy for…
Read More » -
Apnimed Appoints Experienced Pharmaceutical Executive Kevin R. Lind as Chief Executive Officer to Implement Next Phase of Growth Strategy
Mr. Lind succeeds Company founder Lawrence G. Miller, MD, who is transitioning to Vice Chair of the Board Mr. Lind…
Read More » -
Armadin Names Barbara Massa Chief Operating Officer
Former Mandiant and venture capital executive joins Armadin to scale operations as the company advances its agentic attack platform into…
Read More » -
Reco Expands Executive Team and Global Footprint to Accelerate Leadership in Enterprise AI Agent Security
Company appoints COO and new executive team, opens Texas office, expands into UKI, and earns top national reseller rankings. Recognized with…
Read More » -
Trillion Labs is Developing Industrial World Models for AI Factories, built with NVIDIA Omniverse and NVIDIA Nemotron
Trillion Labs’ industrial world models capture how AI Factories — and the plants that power them — actually behave and…
Read More » -
Going Beyond Vibe Coding: Agentic AI Takes on Large-scale System Development
LG CNS and Cline launch “Cline Spec Driven for Enterprise” to bring intelligence across the full enterprise system development and…
Read More » -
Tom Parks joins CAMIN as Chief Financial Officer
PASADENA, Texas, June 8, 2026 /PRNewswire/ — CAMIN, a global leader in independent laboratory testing, inspection and compliance services for…
Read More » -
Most Canadians Say Talking About Fraud Is Key to Reducing Risk and Breaking Stigma, TD Survey Finds
62% believe open conversations could help reduce fraud risk, yet only 23% regularly talk about scams with family TORONTO, June…
Read More » -
Vasa Therapeutics to Deliver Two Presentations on VS-041 at ECM2026, Featuring Preclinical and First-in-Human Data and Ongoing Phase 1c Trial Design in HFpEF
VS-041, a Novel, First-in-Class, Narrow-spectrum Matrix Metalloproteinase Inhibitor Targets theUnderlying Extracellular Matrix Pathology Driving Myocardial Fibrosis and Stiffening ENCINITAS, Calif.,…
Read More »